Skip to main content
. 2024 Feb 27;28(9):2346–2361. doi: 10.1177/13623613241232860

Table 1.

Demographic information.

Non-autistic participants Autistic participants
Range M SD Range M SD p value
Age 12.1–16.9 14.4 1.4 12.5–16.9 14.8 1.0 0.21
IQ 80–135 111 12 80–132.5 107.5 12.6 0.24
AQ 2–22 8.4 5.0 3–22 12.9 4.7 <0.001 a
DIF 7–17 10.5 2.5 7–17 11.8 2.9 0.03 a
DDF 5–15 9.0 2.9 5–15 10.0 2.5 0.14
Motion during scan 0.05–0.26 0.099 0.048 0.05–0.18 0.080 0.027 0.046 a
n % n %
Medication use 0 100 15 42.9
 Methylphenidate 12 34.3
 Antipsychotics 4 11.4
 Other 5 14.3
Comorbidities 0 100 20 57.1
 Dyslexia 9 25.7
 ADHD 8 22.9
 PTSD 2 5.7
 Sensory integration disorder 2 5.7
 Other 4 11.4
Ethnicity
 The Netherlands 31 91.2 33 94.3
 Western Europe 0 0 1 2.9
 South Africa 1 2.9 1 2.9
 USA 1 2.9
 Southeast Asia 1 2.9
Gross annual income
 <€31.000– 2 5.9 3 8.6
 €31.000–€76.000 18 53 16 45.7
 >€76.000– 13 38.2 10 28.6
 Declined to disclose 1 2.9 6 17.1

IQ: estimated based on 2 WISC/WAIS-III subtests: block patterns and similarities; AQ: autism quotient questionnaire measuring autism traits; DIF: alexithymia difficulty identifying feelings; DDF: alexithymia difficulty describing feelings; SD: standard deviation; ADHD: attention-deficit/hyperactivity disorder; PTSD: post traumatic stress disorder.

a

Independent samples t test indicates significant difference between groups.